INBX — Inhibrx Biosciences Inc. stock price, charts and financials

QT56Inhibrx Biosciences Inc.

Inhibrx Biosciences Inc. (NASDAQ: INBX) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
83.53
+0.81+0.98%
OverviewShort InterestFilings
INBXQT56Inhibrx Biosciences Inc.·NASDAQ
83.53+0.98%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 03, 2026SC 13GBeneficial ownership statement (passive)
Jul 16, 20268-KCurrent report
Jun 15, 20268-KCurrent report
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
Jun 04, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 14, 20268-KCurrent report
May 14, 202610-QQuarterly report
May 11, 20268-KCurrent report
Apr 27, 20264Statement of changes in beneficial ownership
Apr 23, 2026DEFA14AAdditional proxy soliciting materials
Apr 23, 2026ARSAnnual report to shareholders
Apr 23, 2026DEF 14ADefinitive proxy statement
Apr 21, 20268-KCurrent report
Mar 19, 20268-KCurrent report
Mar 19, 202610-KAnnual report
Feb 23, 20268-KCurrent report
Feb 17, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Feb 11, 2026SC 13GBeneficial ownership statement (passive)
Jan 21, 2026SC 13GBeneficial ownership statement (passive)
Dec 16, 20258-KCurrent report
Nov 14, 202510-QQuarterly report
#1 / 25 of 291
Page
▼
/ 12